Friday Blog Roundup

Thereâs a lot going on right now with the FDA and drug regulation:

The Health Affairs Blog has posts by Scott Gottlieb (a former FDA official now at the American Enterprise Institute) and Jerome Kassirer (a former editor-in-chief of the New England Journal now at the Tufts University School of Medicine) giving two contrasting responses to FDAâs recently issued draft guidance that would let drug and device manufacturers give doctors journal articles about off-label uses of their products.

Ed Silverman at Pharmalot lets us know that more than half of the post-marketing studies pharamaceutical companies promised FDA theyâd undertake havenât even begun.

Sarah Rubenstein at WSJâs Health Blog reports that the 2004 settlement over off-label marketing of Pfizerâs Neurontin (a pain and epilepsy drug) will be funding projects that advise prescribers and patients about the safety, efficacy, and costs of pharmaceuticals.

Elsewhere:

Max Siegel at RH Reality Check shares his personal story about the effects of abstinence-only education, and explains why he testified before the House Oversight and Government Reform Committee about this experience.

Merrill Goozner at GoozNews tackles the recent news about declining longevity in some parts of the country, and reminds us how tobacco settlement money relates to the problem.

Michael Bérubé at Crooked Timber investigates the presidential candidatesâ policy positions on disability.

Abel Pharmboy at Terra Sigillata commemorates the 94th anniversary of the Ludlow Massacre, and reminds us that the sacrifices of workers and their families have made it possible for so many of us to live the comfortable lives we enjoy today.

Sharon Astyk at Gristmill considers what the word âfarmerâ means around the world.

Matthew Lewis at Triple Pundit offers us a glimpse behind the curtain at the Wall Street Journal editorial page.

Nedra Weinreich at Spare Change checks out the Zombie Squad approach to public health preparedness.

Categories

More like this

While we here at The Pump Handle have been focusing on popcorn problems (the big story is here, the latest installment here), other bloggers have been keeping tabs on public health issues in Congress: At RH Reality Check, Anika Rahman and Tod Preston explain the Global Gag Rule and why itâs a good…
What's new at the FDA? Ed Silverman at Pharmalot reports on FDA plans to spend some of its user-fee money on post-marketing safety activities. Merrill Goozner at GoozNews warns that the FDA is scrapping the Helsinki Declaration on protecting human subjects. Jacob Goldstein at WSJ's Health Blog…
FDA has been in the spotlight this week, and often not in a good way. Andrew Schneider at Secret Ingredients tracks the ongoing saga of the salmonella-tainted tomatoes. At WSJâs Health Blog, Alicia Mundy reports that Congress has pressed more money on the FDA, and Theo Francis describes Senator…
Thereâs been a lot of blogging about vaccines lately: Mark Meier at Science Progress explains how a cocaine-addiction vaccine was developed, and what questions and hurdles it still faces. Jacob Goldstein at WSJâs Health Blog explains what this yearâs mismatched flu vaccine means for next yearâs…

Thanks ever so much for focusing on the Ludlow Massacre post - yes, it's not exactly science but all of us have much to be grateful for in the careers we pursue as a result of sacrifices made by those at Ludlow and elsewhere.